⚠️ Research Use Only. All compounds sold exclusively for in vitro laboratory research. Not for human or veterinary use.
The Venus Protocol is a 10-compound, 100-vial research kit built around women’s biology — covering every relevant pathway from triple-agonist fat loss and skin rejuvenation to cellular longevity, gut healing, GH/sleep quality, and sexual wellness. Every compound was selected for female health relevance. Zero testosterone. Zero anabolic steroids. Zero harsh androgens.
10Compounds
100Vials
6Pathways
≥99%HPLC Purity
0Androgens/Steroids
6 Research Pathways
⚡
Metabolic & Weight Management Retatrutide — GLP-1/GIP/GCGR triple agonist. Direct fat oxidation, appetite suppression, thermogenesis. Phase 2 data: 15–24% weight reduction. The most potent metabolic peptide without androgens.
Gut Health & Tissue Repair BPC-157 + TB-500 — Wolverine Stack synergistic healing. BPC-157 specifically researched for IBS (1.5–3× higher prevalence in women). TB-500 for systemic tissue repair, joint support, angiogenesis.
GH Axis & Sleep Quality CJC-1295 No DAC + Ipamorelin — the gentlest GH secretagogue pairing. Ipamorelin: zero cortisol, zero prolactin elevation. Pulsatile GH for sleep architecture, skin elasticity, body composition.
Sexual Wellness & Libido PT-141 (Vyleesi/Bremelanotide) — MC4R agonist, FDA-acknowledged for female HSDD in premenopausal women. CNS desire pathway activation without hormonal manipulation. RECONNECT trial validated (1,200+ women).
All 10 Compounds
1
Retatrutide 10mg CAS 2381089-83-2 · MW 4731.33 · Triple-Agonist GLP-1/GIP/GCGR
Simultaneously activates GLP-1R (appetite suppression), GIPR (insulin sensitivity/adipose regulation), and GCGR (direct hepatic fat oxidation + thermogenesis). Phase 2 trials showed 15–24% mean weight reduction. The GCGR component is absent in semaglutide and tirzepatide — Retatrutide is the most potent metabolic peptide available without androgenic effects.
Gly-His-Lys:Cu²⁺. Activates collagen I/III/IV, elastin, GAG accumulation, and MMP modulation. Clinical data: 70% of subjects showed measurable collagen increases — outperforming vitamin C and retinoic acid. Modulates 4,000+ genes. Plasma GHK-Cu declines from ~200 ng/mL at 20 to ~80 ng/mL by 60. Hair follicle stimulation research particularly relevant. 100mg/vial.
3
NAD+ 500mg CAS 53-84-9 · MW 663.43 · Nicotinamide Adenine Dinucleotide — Energy & Longevity
Mitochondrial electron carrier and substrate for SIRT1–7, PARPs, CD38. NAD+ declines ~50% between ages 40–60, correlating with accelerated cellular senescence and decreased mitochondrial function. Researched for mitochondrial biogenesis, DNA repair, circadian rhythm maintenance, and energy restoration. 500mg/vial.
γ-L-Glutamyl-L-cysteinyl-glycine. Beyond general antioxidant activity, Glutathione inhibits tyrosinase — the key enzyme in melanin synthesis — shifting production toward lighter pheomelanin for a more even skin tone. Also provides hepatoprotection and Phase II conjugation support. Paired with GHK-Cu for comprehensive skin research. 600mg/vial.
5
BPC-157 10mg CAS 137525-51-0 · MW 1419.53 · Body Protection Compound — Gut & Tissue Repair
15-AA gastric pentadecapeptide. Modulates NO pathways, EGF/FGF/VEGF, FAK-paxillin cascades. IBS affects 1.5–3× more women than men; BPC-157’s gut barrier and motility research is therefore particularly relevant to female biology. Also researched for tendon/ligament healing, neuroprotection. Remarkably stable in gastric acid.
6
TB-500 10mg CAS 77591-33-4 · MW 4963.44 · Thymosin Beta-4 Fragment — Systemic Healing
Actin-binding peptide — cell migration, cytoskeletal dynamics, angiogenesis. Systemic circulation regardless of injection site. Synergistic with BPC-157 in the ‘Wolverine Stack’ for complete tissue repair coverage. Joint support, flexibility, wound healing acceleration, inflammation reduction.
7
PT-141 (Bremelanotide) 10mg CAS 32780-32-8 · MW 1025.18 · MC4R Agonist — Sexual Wellness (Vyleesi)
The only FDA-acknowledged compound for hypoactive sexual desire disorder (HSDD) in premenopausal women (Vyleesi). Activates MC4R in the CNS medial preoptic area and ventromedial hypothalamus — desire pathway activation without manipulating estrogen, progesterone, or testosterone. No androgenic effects. Validated in the RECONNECT programme (1,200+ women).
Ala-Glu-Asp-Gly. Primary mechanism: telomerase activation — the enzyme maintaining telomere length at chromosome ends. Telomeres shorten with each cell division; Epithalon research focuses on preserving this chromosomal integrity. Also researched for melatonin normalisation and antioxidant enzyme upregulation. Paired with NAD+ for dual-mechanism anti-aging.
9
CJC-1295 No DAC 5mg CAS 863288-34-0 · MW 3367.97 · GHRH Analog — GH Axis & Sleep
Modified GRF 1-29, 4 substitutions for stability. Half-life ~30 min → pulsatile GH release preserving natural rhythms. Selected over CJC With DAC specifically because pulsatile (not continuous) GH is more relevant for Venus Protocol’s sleep and body composition research goals. Paired with Ipamorelin.
Pentapeptide GHSR-1a agonist with the highest receptor selectivity of any ghrelin mimetic. Critically: stimulates GH without affecting cortisol, prolactin, or aldosterone. This zero-impact hormonal profile makes it the best-tolerated GH secretagogue for women’s health research. Combined with CJC-1295 for synergistic GH pulses supporting sleep architecture, skin elasticity, body composition.
Stack Specifications
Total
10 compounds · 100 vials
Androgens
None — zero testosterone, zero anabolic steroids, zero androgenic compounds
Form
All 10 lyophilized powder
Purity
≥99% HPLC · MS confirmed · every batch
COA
Janoshik independent — publicly verifiable
Shipping
Domestic: USA · EU · UK · Canada · Australia · International
Payment
BTC · USDT ERC-20
Men’s Research? See the Clavicular Ascension Stack
The Clavicular Ascension Stack is the 12-compound men’s health counterpart — including Retatrutide, Melanotan II, HGH, IGF-1 LR3, GHK-Cu, NAD+, Testosterone Cypionate, Glutathione, BPC-157, TB-500, CJC-1295, and Anavar. View Ascension Stack →
The Venus Protocol is a 10-compound, 100-vial women’s health research kit designed specifically for female biology. It covers 6 pathways: metabolic/weight management (Retatrutide), skin/collagen (GHK-Cu + L-Glutathione), cellular longevity (NAD+ + Epithalon), gut and tissue repair (BPC-157 + TB-500), GH axis and sleep (CJC-1295 No DAC + Ipamorelin), and sexual wellness (PT-141/Vyleesi). Zero testosterone, zero anabolic steroids, zero androgenic compounds.
How is the Venus Protocol different from the Clavicular Ascension Stack?
The Clavicular Ascension Stack is designed for men’s research protocols and includes Testosterone Cypionate, Melanotan II, IGF-1 LR3, HGH, and Anavar — androgenic and anabolic compounds. The Venus Protocol replaces all androgenic compounds with women’s-health-specific ones: PT-141 for sexual wellness (FDA-acknowledged for HSDD in women), Epithalon for telomere/longevity research, and Ipamorelin as the most cortisol- and prolactin-neutral GH secretagogue.
What makes PT-141 specifically relevant for women?
PT-141 (Bremelanotide/Vyleesi) is an MC4R agonist that activates desire pathways in the CNS (medial preoptic area, ventromedial hypothalamus) rather than manipulating sex hormones. It is the only FDA-acknowledged compound for hypoactive sexual desire disorder (HSDD) in premenopausal women, validated in the RECONNECT clinical programme (1,200+ women). It has no androgenic effects.
Why is Epithalon in the Venus Protocol?
Epithalon (Ala-Glu-Asp-Gly) activates telomerase — the enzyme maintaining telomere length. Telomeres shorten with each cell division; critically short telomeres trigger cellular senescence. Paired with NAD+ for dual-mechanism anti-aging: mitochondrial function (NAD+) and chromosomal integrity (Epithalon). This combination is particularly relevant to women’s longevity research given accelerated telomere attrition observed post-menopause.
Why CJC-1295 + Ipamorelin specifically for women?
Ipamorelin has the highest receptor selectivity of any ghrelin mimetic — it stimulates GH release without affecting cortisol, prolactin, or aldosterone. For women’s health research, this clean hormonal profile is critical because elevated cortisol (common with other GH secretagogues like GHRP-6) and elevated prolactin are undesirable. The CJC-1295 + Ipamorelin pairing provides the gentlest, most well-tolerated GH secretagogue combination available.
Does the Venus Protocol contain any androgens or steroids?
No. The Venus Protocol is entirely free of testosterone, anabolic steroids, androgenic compounds, and hormone precursors. All 10 compounds were specifically selected for relevance to women’s biology without virilisation risk.
